Equities

Avant Brands Inc

Avant Brands Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.085
  • Today's Change0.00 / 0.00%
  • Shares traded19.66k
  • 1 Year change-48.48%
  • Beta3.4790
Data delayed at least 15 minutes, as of May 02 2024 18:32 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Avant Brands Inc. is a Canada-based cannabis company. The Company produces handcrafted cannabis products. Its products are distributed via three sales channels: recreational, medical and export. The Company's recreational brand portfolio includes BLK MKT, Tenzo, Cognoscente, and Treehugger, which are produced from cultivars, and sold in British Columbia, Saskatchewan, Manitoba, Ontario, Atlantic Canada and the territories. The Company's medical cannabis brand, GreenTec, which is distributed nationwide, directly to patients through its GreenTec Medical portal, and through various medical cannabis partners. The Company has various licensed and operational production facilities across Canada, which produce its consumer brands sold across medical and recreational channels in Canada. Its subsidiaries include Avant Craft Cannabis Inc., GreenTec Bio-Pharmaceuticals Inc., GreenTec Retail Ventures Inc., Grey Bruce Farms Incorporated, Tumbleweed Farms Corp. and Spectre Labs Inc., among others.

  • Revenue in CAD (TTM)27.39m
  • Net income in CAD-7.95m
  • Incorporated2017
  • Employees180.00
  • Location
    Avant Brands Inc1632 Dickson Avenue, Suite 335KELOWNA V1Y 7T2CanadaCAN
  • Phone+1 (778) 760-8338
  • Fax+1 (416) 915-4265
  • Websitehttps://avantbrands.ca/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ceapro Inc9.63m-4.71m19.18m12.00--0.6886--1.99-0.0602-0.06020.12310.35580.27851.256.45---13.622.46-14.422.5941.0752.27-48.895.135.49-39.490.07470.00-48.87-3.64-207.09---3.60--
Rubicon Organics Inc40.12m-1.82m20.51m180.00--0.541215.480.5113-0.0323-0.03230.71070.67440.72281.239.92222,869.30-3.29-18.76-4.25-24.9363.2755.64-4.55-42.420.932215.080.2154--12.95--52.71---21.38--
Numinus Wellness Inc23.14m-26.99m23.73m----2.38--1.03-0.1022-0.10220.08770.03150.7724--11.76---90.11-77.31-106.01-84.2033.28---116.66-323.32---14.790.3876--256.95--32.59------
Avant Brands Inc27.39m-7.95m24.18m180.00--0.4849--0.8829-0.0295-0.02950.10430.17530.34410.97125.02152,172.20-9.95-15.93-12.87-19.5039.7037.78-28.90-63.750.7269-1.250.262--30.75240.2632.78---23.24--
Simply Better Brands Corp109.71m-33.32m25.47m--------0.2322-0.4645-0.46451.55-0.06882.846.7922.87---86.36-63.90-460.44-215.4858.69---30.37-29.460.298-8.191.65--22.08---96.41------
Aptose Biosciences Inc0.00-70.35m26.90m35.00---------10.67-10.670.00-0.50180.00----0.00-159.98-63.94-280.87-71.96---------------------22.44---38.48--
Data as of May 02 2024. Currency figures normalised to Avant Brands Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.